质子跨膜转运能够引起艾氏腹水癌细胞质膜表面质子化

荧光探针Ｆｌｕｏｒｅｓｃｅｉｎ－ＰＥ在８ｍｍｏｌ／Ｌ Ｃａ＾２＋促进下,能够标记于艾氏腹水癌细胞质膜表面。在不影响膜结构的条件下,利用微量ＴｒｉｔｏｎＸ－１００消除膜表面与介质之间的质子浓度差,通过酸滴定实验,能够得到膜表面ＰＨ与ＦＰＥ荧光强度之间的相关曲线。根据此曲线测定了艾氏腹水癌细胞质膜表面ＰＨ：当介质ＰＨ为７．２时,其膜表面ＰＨ为６．７,其质子浓度大约为介质中的３倍,质子跨膜转运抑制剂ＣＣ     

不同单位保种的S180细胞核型及DNA含量的比较研究

对四个单位保种的S180 细胞经KM 小鼠腹腔传代,体外培养加秋水仙碱,涂片、染色后,显微镜下计数染色体数目:腹水传代的S180 细胞,用70 % 乙醇固定,流式细胞仪测DNA 含量。结果如下:本学部( 本部) ,中国医学科学院药物所( 药物所) ,武汉大学保种中心( 武汉大学) 和北京市肿瘤所( 肿瘤所) 保种的S180 细胞株,其染色体均数分别为62-8 ±22-8 ,69-1 ±21-2,39-9 ±8-26 ,58-7±9-75 条。四单位S180 细胞株染色体数做方差分析表明,除肿瘤所与本部外,其它两单位比较均有显著统计学差异(P< 0-01) 。直方图分析显示主流染色体范围分别为56 ～60 ,61 ～65,41 ～45,61 ～65 条。流式细胞术DNA 含量分析表明肿瘤所S180 DNA含量最多,武汉大学保种的S180 细胞的DNA含量最少。这些结果均证明四个单位的S180 细胞株在一些方面已出现显著差异。     

精氨酸对艾氏腹水癌细胞体外作用的机制探讨

本研究采用小鼠艾氏腹水癌细胞探讨了精氨酸对一些肿瘤细胞体外作用的可能机制。结果表明精氨酸对艾氏腹水癌细胞体外蛋白质合成有显著的抑制作用,其作用受培养介质中一些氨基酸的影响;细胞内游离氨基酸浓度分析结果提示精氨酸的作用可能并不是通过干扰细胞内游离氨基酸池所引起,其具体作用机制尚待进一步实验的揭示。     

艾氏腹水癌患鼠腹水中一种高分子量DNA结合蛋白的分离

 本文利用免疫吸收法和免疫亲和层析法,从艾氏腹水癌患鼠腹水DNA结合蛋白中,分离得到了一种高分子量DNA结合蛋白。在免疫双扩散反应中,它与抗艾氏腹水癌患鼠血清DNA结合蛋白的兎抗血清反应形成一条沉淀线,但与正常小鼠血清DNA结合蛋白的兎抗血清不形成沉淀线。该DNA结合蛋白样品用2-巯基乙醇还原后,经SDC-PAGE分析,测得其分子量约为41000。     

不同单位保存的艾氏腹水癌细胞(EAC)的某些生物学特性比较研究

目的比较研究不同单位保种的EAC瘤株生物学特性的差异.方法选择研究了北京市肿瘤研究所、山东省医学科学院药物研究所及武汉大学保种中心保存EAC细胞的大小,细胞株体外培养时对血清的依赖性,接种小鼠皮下建立肿瘤动物模型肿块生长曲线,建立的动物模型对环磷酰胺CTX治疗的敏感性等指标.结果发现三个单位保存的EAC细胞形态及大小基本一致;北京EAC体外培养容易生长,7.5%NCS即可生长良好,山东及武汉EAC体外培养生长力较弱;皮下接种BALB/c小鼠后,北京EAC最易生长肿瘤,武汉EAC次之,山东EAC最差;建立的动物模型对CTX治疗的敏感性,依次为北京EAC,武汉EAC,山东EAC,用CTX治疗的抑瘤率相应为82.9%,71.9%,50%.结果可见三个不同单位保种的EAC瘤细胞生物学特性确已存在显著差异.     

艾氏腹水癌细胞核糖核酸体外对C_(57)BL/6脾自然杀伤活性的影响

本文采用~(51)Cr释放法,研究了艾氏腹水癌细胞核糖核酸(EAC-RNA)体外对C_(57)BL/6小鼠脾自然杀伤细胞(NK)对YAC-1靶细胞杀伤活性的影响。结果表明,EAC-RNA能显著抑制NK活性。经RNase处理后,其抑制活性消失,DNase或Pronase的处理不改变其抑制活性。     

肝硬化患者无菌腹水中真菌DNA的检测及易位研究

目的检测和分析肝硬化患者无菌腹水中真菌DNA存在状况。方法选取118例无菌腹水的肝硬化患者为研究对象,分别采集患者刚入院时的腹水、血液和粪便标本。应用PCR技术直接检测标本的真菌DNA并克隆测序。并收集患者临床资料,对患者临床症状及检验结果进行分析比较。结果1名患者的腹水、血液、粪便中同时检测到真菌DNA,14名患者的腹水和粪便中同时检测到真菌DNA,3名患者的血液和粪便中同时检测到真菌DNA,大部分序列间的相似性高于99％。测序检测到最多的菌种为Candidaalbicans。结论肝硬化患者无菌腹水中能够检测到真菌DNA,并且提示在肝硬化患者腹水和血清中检测到的真菌DNA易位于肠道。     

三单位保存的艾氏腹水癌细胞株及克隆细胞蛋白质表达

目的　比较三个单位保存的艾氏腹水癌 (EAC)细胞株及克隆细胞的蛋白质表达。方法　对北京市肿瘤研究所 (北京 )保存的EAC进行克隆培养 ,从中选出 5株克隆 ;对武汉大学保种中心 (武汉 )、山东省医学科学院药物研究所 (山东 )及北京保存的EAC细胞株及 5株克隆细胞的SDS PAGE电泳图谱及免疫组化蛋白质分布进行了对比。结果　武汉、山东及北京保存的EAC的电泳条带数分别为 2 2、2 5及 2 8条 ,而克隆细胞E2G8为 2 6条带。三单位EAC瘤细胞对 5种抗体做免疫组化染色 ,与 1株抗体反应的阳性细胞比例均较高 ,差异无显著性 (P >0 0 5 ) ,与另 4种抗体反应的阳性细胞率差异有显著性 ;5株克隆细胞对 10种抗体作免疫组化染色 ,其中克隆细胞E2G8、E2F4与 7种抗体反应阳性 ,E2C6与 8种抗体反应阳性 ,E1G5、E2B5与 6种抗体反应阳性。克隆细胞一旦与某种抗体反应阳性 ,阳性细胞的比例即在 85 %以上。结论　不同单位保存的EAC细胞株及克隆细胞株蛋白质表达有差异     

艾氏腹水癌细胞膜质子跨膜外转运与脂质体融合:Ca2+及脂质体膜脂成份的作用

研究了Ca^2 及脂质体膜脂成分对艾氏腹水癌细胞质膜质子跨膜转运驱动的脂质体融合中的作用。结果 表明Ca^2 促进质子跨膜转运驱动的质子跨膜转运驱动艾氏腹水癌细胞与脂质体间的融合,膜融合程度与膜表面电荷密度的相关曲线显示,在下述条件膜融合与膜表面电荷密度呈正相关：（1）介质Ca^2 浓度小于6mmol/L,脂质体磷脂组成为PE：PC：CL＝6：2：2;（2）介质Ca^2 浓度为6mmol/L,脂质体鳞脂组成为PE：PC：CL＝6：2：2;（3）无Ca^2 介质,脂质体磷脂组成为PE：CL＝8：2;（4）介质Ca^2 浓度10mmol/L,脂质体磷脂组成为PE：CL＝8：2。脂质体PE／PC含量对膜融合的影响表明,当PE含量减少PC含量增加时,膜融合程度不断下降,提示影响膜融合的另一因素可能是生物膜结构形成“柄”融合中介体的能力。     

Anisomycin诱导小鼠艾氏腹水癌细胞凋亡

目的：探讨Anisomycin诱导EAC细胞凋亡的机制。方法：利用MTT法观察Anisomycin对EAC细胞增殖的影响;应用An．nexinV—FITC和PI双染色检测Anisomycin作用下EAC细胞凋亡的变化;琼脂糖凝胶电泳检测Anisomycin作用下EAC细胞的DNA断裂片断;采用RT—PCR检测Anisomycin作用下Caspase-3mRNA的转录水平;WesternBlot分析Anisomycin处理的EAC细胞内Caspase-3蛋白的表达。结果：Anisomycin对EAC细胞增殖的抑制率随浓度的升高而增高,EAC细胞的凋亡水平也上升,随着Anisomycin浓度升高EAC细胞DNA断裂的寡核苷酸片段亦越趋明显,Caspase-3的mRNA和蛋白水平也上调,并明显高于阿霉素组。结论：结果表明,Anisomycin能够抑制EAC细胞的增殖,在体外可能通过激活Caspase-3凋亡信号而诱导EAC细胞的凋亡。     

Anisomycin诱导小鼠艾氏腹水癌细胞凋亡

目的:探讨Anisomycin诱导EAC细胞凋亡的机制。方法:利用MTT法观察Anisomycin对EAC细胞增殖的影响;应用AnnexinV-FITC和PI双染色检测Anisomycin作用下EAC细胞凋亡的变化;琼脂糖凝胶电泳检测Anisomycin作用下EAC细胞的DNA断裂片断;采用RT-PCR检测Anisomycin作用下Caspase-3 mRNA的转录水平;Western Blot分析Anisomycin处理的EAC细胞内Caspase-3蛋白的表达。结果:Anisomycin对EAC细胞增殖的抑制率随浓度的升高而增高,EAC细胞的凋亡水平也上升,随着Anisomycin浓度升高EAC细胞DNA断裂的寡核苷酸片段亦越趋明显,Caspase-3的mRNA和蛋白水平也上调,并明显高于阿霉素组结论:结果表明,Anisomycin能够抑制EAC细胞的增殖,在体外可能通过激活Caspase-3凋亡信号而诱导EAC细胞的凋亡。     

Carcinoma Infection and Immune Systems of Ehrlich Ascites Carcinoma-Bearing Mice Treated with Structurally Similar Sulfonium Compounds

The effects of intraperitoneal administration of dimethylsulfonioacetate (DMSA), dimethlsulfoniopropionate (DMSP), and methylmethionine (MeMet) solutions (10 mM each) on the body weights and the hematological parameters (red and white blood cells) of Ehrlich ascites carcinoma (EAC)-bearing mice were examined for up to 10 d. Body weights significantly increased in the EAC-bearing mice treated with and without MeMet in contrast to those with DMSA and DMSP. This increase was attributed to the increased amounts of ascitic fluid. EAC-bearing mice with and without MeMet both showed abnormal values of hematological parameters, while those with DMSA and DMSP exhibited almost normal levels on the 10th day.     

Chemical Constituents of Cape Aloe and Their Synergistic Growth-Inhibiting Effect on Ehrlich Ascites Tumor Cells

The constituents of cape aloe were investigated after a preliminary screening of the growth-inhibiting effect on Ehrlich ascites tumor cells (EATC) of several extracts of this plant. Ten compounds were isolated from the dichloromethane (CH₂Cl₂) extract that showed the strongest activity, and their structures were elucidated as aloe-emodin (1), p-hydroxybenzaldehyde (2), p-hydroxyacetophenone (3), pyrocatechol (4), 10-oxooctadecanoic acid (5), 10-hydroxyoctadecanoic acid (6), methyl 10-hydroxyoctadecanoate (7), 7-hydroxy-2,5-dimethylchromone (8), furoaloesone (9), and 2-acetonyl-8-(2-furoylmethyl)-7-hydroxy-5-methylchromone (10) based on MS and various NMR spectroscopic techniques. Compounds 2–7 were isolated for the first time from cape aloe. Compounds 4–7 and 10 showed a significant growth-inhibiting effect, and compound 1 exhibited a remarkable synergistic effect on compounds 8–10, which was not observed with the treatment by each compound alone on EATC. These results suggest that the strong growth-inhibiting effect of the CH₂Cl₂ extract was dependent not on one compound alone, but on the synergistic effect from the combination of compound 1 and the other compounds.     

A flavone from the ethyl acetate extract of Leea rubra leaves with DNA damage protection and antineoplastic activity

Among the major constituents of Leea rubra (Family Vitaceae) leaves, phenolic and flavonoind compounds are most important for therapeutic purposes and the plant parts have been used in traditional medicine to treat several diseases for long. Thus, in order to scientifically confirm the traditional uses of the L. rubra leaves, the present study was designed to investigate the efficacy of the isolated flavones against AAPH induced oxidative damage to pUC19 DNA by gel electrophoresis and antineoplastic activity was evaluated on Ehrlich ascites carcinoma (EAC) bearing Swiss albino mice by evaluating percentage inhibition of cell growth, morphological changes of EAC cells and hematological parameters of the mice. The isolation was carried out by column chromatography and structure was revealed by ¹H-NMR and ¹³C NMR. The result shows that, the isolated compound was identified as myricetin 4'-methoxy-3-O-α-l-rhamnopyranoside based on previously reported data. The isolated flavone effectively inhibited AAPH-induced oxidative damage to DNA; because it could inhibit the formation of circular and linear forms of the DNA. In anti-proliferative assay, 76% growth inhibition of EAC cells was observed as compare to the control mice (p<0.05) at a dose 100 mg/kg body weight. Thus the isolated flavone showed great importance as a possible therapeutic agent in preventing oxidative damage to DNA and the chronic diseases caused by such DNA damage, and can also become important in cancer chemotherapy.     

Characterization of gangliosides from Ehrlich ascites tumour cells and their variants

Differences in the nature of the gangliosides present in two types of Ehrlich ascites tumour (EAT) cells, the adherent and non-adherent EAT cells, were studied. Gangliosides were isolated by DEAE Sephadex column chromatography and analysed by high-performance thin-layer chromatography (HPTLC). The non-adherent EAT (na-EAT) cells which grow in the peritoneal cavity of mice were selected for growth on basement membrane and tissue culture plastic to give the adherent EAT (a-EAT) cells. na-EAT cells contained 1.57 nmol lipid-bound sialic acid per mg protein and at least 12 different gangliosides, including major gangliosides such as GM3, GM2, GM1, GD3, GD1a and GT1b. On the other hand, the ganglioside pattern of a-EAT cells differed significantly from that of na-EAT cells, both quantitatively and qualitatively. The content of lipid-bound sialic acid in a-EAT cells was only 0.24 nmol per mg of protein. The gangliosides in a-EAT cells were characterized as GD1a and trisialogangliosides and, significantly, a-EAT cells did not contain monosialogangliosides. Neutral glycolipids were isolated from both cell lines and their patterns were compared. In contrast to the gangliosides pattern, their neutral glycolipid patterns were similar. Glucosylceramide and lactosylceramide were the major components in both types of cells. In addition to na- and a-EAT cells, a-EAT cells were passaged in mice by intraperitoneal injection, giving rise to a third variant (c/m EAT cells). We analysed the gangliosides in c/m EAT cells to determine whether there was a change in the ganglioside pattern found in na-EAT cells. After repeated passage of c/m EAT cells in mice, the pattern of gangliosides shifted to that of na-EAT cells. Alterations of ganglioside composition may be associated with the growth environment of the murine peritoneal cavity; alternatively, a selection process may have occurred.Abbreviations EAT cells Ehrlich ascites tumour cells - na-EAT cells non-adherent EAT cells - a-EAT cells adherent EAT cells - c/m EAT cells cultured a-EAT cells passaged in mice - HPTLC high-performance thin-layer chromatography - PBS 10 mM phosphate-buffered saline, pH 7.2, containing 0.15 M NaCl - EDTA ethylene-diaminetetraacetic acid - TFA trifluoroacetic acid - TG thioglycollate - Cer ceramide (N-fatty acyl sphingosine) - GM3 NeuAc2-3Gal1-4Glc-Cer - GM2 GalNAc1-4(NeuAc2-3)Gal1-4Glc-Cer - GM1a Gal1-3GalNAc1-4(NeuAc2-3)Gal1-4Glc-Cer - GD3 NeuAc2-8NeuAc2-3Gal1-4Glc-Cer - GD1a NeuAc2-3Gal1-3GalNAc1-4(NeuAc2-3)Gal1-4Glc-Cer - GT1b NeuAc2-3Gal1-3GalNAc1-4(NeuAc2-8NeuAc2-3)Gal1-4Glc-Cer - LacCer Gal1-4Glc-Cer - Gb3 Gal1-4Gal1-4Glc-Cer - Gb4 GalNAc1-4Gal1-4Gal1-4Glc-Cer This paper is dedicated to my esteemed colleague, Sen-itiroh Hakomori on the occasion of his 65th birthday.